The National Cancer Institute’s Molecular Analysis for Therapy Choice (NCI-MATCH) trial, the largest precision medicine trial of its kind, has
Continue reading »
mypharmacynews.com
Home » Colon Cancer »
The National Cancer Institute’s Molecular Analysis for Therapy Choice (NCI-MATCH) trial, the largest precision medicine trial of its kind, has
Continue reading »Walter and Eliza Hall Institute researchers have visualised for the first time how the protein SOCS1 ‘switches off’ cell signalling
Continue reading »“Possibly carcinogenic and should be investigated more closely.” For forty years, this has been the conclusion of researchers who have
Continue reading »When scientists at The University of Texas Health Science Center at Houston (UTHealth) applied a chemical found in soybeans to
Continue reading »The most common heart medications may get an assist from nitric oxide circulating in the body, according to a new
Continue reading »Kidney cancer, one of the ten most prevalent malignancies in the world, has increased in incidence over the last decade,
Continue reading »In 1995, two University of Chicago-based cancer specialists suggested there was an intermediate state — somewhere between curable localized cancers
Continue reading »New evidence from a Cochrane review published today, led by a University of Birmingham scientist, suggests that alternative drugs may
Continue reading »Obesity is a known risk factor for certain types of cancer, including colon, pancreatic and breast cancer. Studies have shown
Continue reading »Mistaken belief in mythical causes of cancer is rife according to new research jointly funded by Cancer Research UK and
Continue reading »